ZIM Laboratories Limited (BOM:541400)

ZIM Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	-	251.22	19.47	96	64.21	34.2
Short-Term Investments	-	151.3	0.9	2.84	-	-
Cash & Short-Term Investments	402.52	402.52	20.37	98.84	64.21	34.2
Cash Growth	1876.42%	1876.42%	-79.40%	53.95%	87.72%	145.62%
Accounts Receivable	-	1,090	1,069	1,035	987.12	977.47
Other Receivables	-	0.71	0.76	0.34	0.28	0.39
Receivables	-	1,091	1,070	1,035	987.4	978.08
Inventory	-	937.75	864.7	812.63	537.06	752.84
Prepaid Expenses	-	29	24.01	18.3	17.55	9.81
Other Current Assets	-	297.72	334.04	311.49	303.27	346.43
Total Current Assets	-	2,758	2,313	2,276	1,909	2,121
Property, Plant & Equipment	-	2,152	2,024	1,804	1,216	1,069
Long-Term Investments	-	0.5	0.5	0.52	0.52	0.52
Goodwill	-	1.69	1.69	1.69	1.69	1.69
Other Intangible Assets	-	419.49	321.74	224.9	139.21	103.49
Long-Term Deferred Tax Assets	-	4.6	2.51	-	-	-
Other Long-Term Assets	-	57.58	59.25	160.13	149.3	120.57
Total Assets	-	5,394	4,723	4,468	3,416	3,416

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	-	729.29	695.06	623.81	582.39	810.71
Accrued Expenses	-	102.93	101.38	78.83	83.93	51.18
Short-Term Debt	-	621.3	524.61	550.4	228.8	173.45
Current Portion of Long-Term Debt	-	192.66	194.04	157.12	120.63	150.4
Current Portion of Leases	-	27.43	35.64	24.72	15.72	14.07
Current Income Taxes Payable	-	25.76	29.2	-	-	20.66
Current Unearned Revenue	-	-	-	4.88	3.66	4.48
Other Current Liabilities	-	204.56	83.72	154.5	72.74	234.17
Total Current Liabilities	-	1,904	1,664	1,594	1,108	1,459
Long-Term Debt	-	415.88	403.01	356.01	246.25	189.23
Long-Term Leases	-	8.32	20.7	29.5	10.18	7.22
Long-Term Deferred Tax Liabilities	-	104.2	113.01	101.01	48.03	3.63
Total Liabilities	-	2,432	2,200	2,081	1,412	1,659

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	-	535	487.26	487.26	487.26	162.42
Additional Paid-In Capital	-	381.46	80.3	80.3	80.3	409.89
Retained Earnings	-	1,759	1,701	1,585	1,416	1,177
Comprehensive Income & Other	-	286.47	253.62	234.97	19.61	8.23
Total Common Equity	2,962	2,962	2,522	2,387	2,003	1,757
Minority Interest	-	0.01	0.01	0	-	-
Shareholders' Equity	2,962	2,962	2,522	2,387	2,003	1,757
Total Liabilities & Equity	-	5,394	4,723	4,468	3,416	3,416

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	1,266	1,266	1,178	1,118	621.58	534.37
Net Cash (Debt)	-863.07	-863.07	-1,158	-1,019	-557.38	-500.17
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-17.25	-17.62	-23.76	-20.91	-11.44	-10.26
Filing Date Shares Outstanding	53.56	53.5	48.73	48.73	48.73	48.73
Total Common Shares Outstanding	53.56	53.5	48.73	48.73	48.73	48.73
Working Capital	-	854.16	649.43	682.23	801.61	662.27
Book Value Per Share	55.36	55.36	51.77	49.00	41.12	36.06
Tangible Book Value	2,540	2,540	2,199	2,161	1,863	1,652
Tangible Book Value Per Share	47.48	47.48	45.13	44.35	38.23	33.90
Land	-	96.16	96.16	96.16	96.16	96.16
Buildings	-	845.19	819.87	790.03	503.21	471.4
Machinery	-	1,433	1,364	1,338	1,018	943.73
Construction In Progress	-	587.6	440.54	235.16	178.39	50.97

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 17, 2026

Data Sources Report a data error